Stephane Fattori

Marseille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti-PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast Cancer.

Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti-PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast Cancer.

Journal: Cancer immunology research

Published: December 13, 2024

Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical Cancer.

Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical Cancer.

Journal: Cancer immunology research

Published: October 09, 2024

Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell Pyroptosis.

Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell Pyroptosis.

Journal: Cancer immunology research

Published: October 26, 2023

CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer.

CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer.

Journal: Cancer research

Published: February 23, 2023

Artificial intelligence contribution to multi-omic data in the treatment of breast cancers by neoadjuvant chemotherapy

Artificial intelligence contribution to multi-omic data in the treatment of breast cancers by neoadjuvant chemotherapy

Journal: Medecine sciences : M/S

Published: October 11, 2022

Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy.

Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy.

Journal: Seminars in immunopathology

Published: September 15, 2022

High-throughput mass cytometry staining for deep phenotyping of human natural killer cells.

High-throughput mass cytometry staining for deep phenotyping of human natural killer cells.

Journal: STAR protocols

Published: June 03, 2022

Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer.

Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 30, 2022

Therapeutic Targeting of Tumor-Infiltrating Regulatory T Cells in Breast Cancer.

Therapeutic Targeting of Tumor-Infiltrating Regulatory T Cells in Breast Cancer.

Journal: Cancer research

Published: March 01, 2022

High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.

High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 29, 2021

Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology.

Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology.

Journal: Biomedicines

Published: May 13, 2021

Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2+ γδ T Cell Alterations with Lymph Node Invasion.

Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2+ γδ T Cell Alterations with Lymph Node Invasion.

Journal: Cancers

Published: November 30, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026